Xenotherapeutics Foundation

Xenotherapeutics is a non-profit biotechnology organization dedicated to advancing the science of xenotransplantation to solve the chronic shortage of human organs and tissues. The foundation's lead product, Xeno-Skin, utilizes genetically engineered porcine skin from "Gal-free" swine to provide a temporary, life-saving covering for patients with severe burns. In 2019, the company achieved a major milestone by conducting the first-in-human clinical trial of a live-cell xenotransplant cleared by the FDA. Beyond dermatology, Xenotherapeutics is exploring applications for its platform in nerve repair and complex organ replacement. The organization operates through a unique non-profit model to accelerate clinical translation and ensure broad access to regenerative therapies.